The relationship between pretreatment anaemia and survival in patients with adult soft tissue sarcoma

Journal of Orthopaedic Science

Volumn 18, Issue 6, 2013, Pages 987-993

  Nakamura, Tomoki ^a,b   Grimer, Robert ^a   Gaston, Czar ^a   Carter, Simon ^a   Tillman, Roger ^a   Abudu, Adesegun ^a   Jeys, Lee ^a   Sudo, Akihiro ^b  

^a ROYAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SOFT TISSUE SARCOMA; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; CAUSE OF DEATH; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SARCOMA; SEVERITY OF ILLNESS INDEX; SOFT TISSUE NEOPLASMS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84890437925     PISSN: 09492658     EISSN: 14362023     Source Type: Journal    
DOI: 10.1007/s00776-013-0454-6     Document Type: Article

References (17)

1. Stojadinovie A, Leung DHY, Hoos A, Jaques DP, Lewis JJ, Brennan MF. Analysis of the prognostic significance of microscopic margins in 2084 localized primary adult soft tissue sarcoma. Ann Surg. 2002;235:424-34.
2. Stefannovski PD, Bidoli E, De Paoli A, Buonadonna A, Boz G, Libra M, Morassut S, Rossi C, Carbone A, Frustaci S. Prognostic factors in soft tissue sarcomas: a study of 395 patients. EJSO. 2002;28:153-64.
3. Lewis JJ, Antonescu CR, Leung DH, Blumberg D, Healey JH, Woodruff JM, Brennan MF. Synovial sarcoma: a Multivariate analysis of prognostic factor in 112 patients with primary localized tumors of the extremity. J Clin Oncol. 2000;18:2087-94.
4. Ludwig H, Van Belle S, Barrett-Lee P, Birqeqard G, Bokemeyer C, Gascon P, Kosmidis P, Krzakowski M, Nortier J, Olmi P, Schneider M, Schrijvers D. The European Cancer Anaemia Survey (ECAS): a large multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer. 2004;40:2293-306.
5. Martin F, Santolaria F, Batista N, Milena A, Gonzalez-Reimers E, Brito MJ, Oramas J. Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer. Cytokine. 1999;11:80-6.
6. Falkensammer CE, Thurnher M, Leonhartsberger N, Ramoner R. C-reactive protein is a strong predictor for anaemia in renal cell carcinoma: role of IL-6 in overall survival. BJU Int. 2011;107:1893-8.
7. Zakraoui L, Cheour I, Jeridi T, Jellouli N, Berqaoui N, Moalla M, Abdeladhim A, Karoui M. Ben Hamida A, Zouari R. Prognostic factors in multiple myeloma. Critical analysis based on a multicenter study of 53 cases. Tunis Med. 1988;66:663-72.
8. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271-6.
9. Nieken J, Mulder NH, Buter J, Vellenga E, Limburg PC, Piers DA, de Vries EG. Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients. Blood. 1995;86:900-5.
10. Mori K, Fujimoto-Ouchi K, Onuma E, Noguchi M, Shimonaka Y, Yasuno H, Nishimura T. Novel models of cancer-related anemia in mice inoculated with IL-6-producing tumor cells. Biomed Res. 2009;30:47-51.
11. Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC. Acute-phase response of human hepatocytes; regulation of acute-phase protein synthesis by interleukin-6. Hepatology. 1990;12:1179-86.
12. Leyvraz S, Jelic S. ESMO Guidelines Task Force. ESMO Minimum Clinical Recommendation for diagnosis, treatment and follow-up of soft tissue sarcomas. Ann Oncol. 2005;16(Suppl 1):i69-70.
13. Grimer R, Judson I, Peake D, Seddon B. Guidelines for the management of soft tissue sarcomas. Sarcoma. 2010;2010:506182.
14. Dusick DM. Spearman rank correlation. http://bold-ed.com/corrsp.htm. Accessed 12 June 2013.
15. Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systematic, quantitative review. Cancer. 2001;91:2214-21.
16. Bacci G, Ferrari S, Bertoni F, Rimondini S, Longhi A, Bacchini P, Forni C, Manfrini M, Donati D, Picci P. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Orthpedico Rizzoli. J Clin Oncol. 2000;18:4-11.
17. Rutkowski P, Kaminska J, Kowalska M, Ruka W, Steffen J. Cytokine serum levels in soft tissue sarcoma patients: correlations with clinico-pathological features and prognosis. Int J Cancer. 2002;100:463-71.